Interestingly, all these findings show that platinum resistance of ovarian cancer cells can be reversed by inhibiting mTOR (mTORC1/mTORC2), as specific mRNAs encoding survival, cell cycle, and other functions are inhibited[57,99]. This evidence concerns the gene MTOR and ovarian carcinoma.